Windward Capital Management Co. CA lifted its stake in shares of Metlife Inc (NYSE:MET) by 14.0% in the fourth quarter, Holdings Channel reports. The fund owned 126,540 shares of the financial services provider’s stock after acquiring an additional 15,572 shares during the quarter. Windward Capital Management Co. CA’s holdings in Metlife were worth $6,398,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. PGGM Investments lifted its holdings in shares of Metlife by 2.3% during the 3rd quarter. PGGM Investments now owns 576,944 shares of the financial services provider’s stock worth $29,972,000 after acquiring an additional 12,978 shares during the last quarter. Rockefeller Financial Services Inc. lifted its holdings in shares of Metlife by 189.7% during the 3rd quarter. Rockefeller Financial Services Inc. now owns 37,153 shares of the financial services provider’s stock worth $1,930,000 after acquiring an additional 24,330 shares during the last quarter. Dai Ichi Life Insurance Company Ltd lifted its holdings in shares of Metlife by 49.1% during the 2nd quarter. Dai Ichi Life Insurance Company Ltd now owns 140,168 shares of the financial services provider’s stock worth $7,701,000 after acquiring an additional 46,175 shares during the last quarter. Intl Fcstone Inc. bought a new stake in shares of Metlife during the 2nd quarter worth $383,000. Finally, Calamos Wealth Management LLC lifted its holdings in shares of Metlife by 6.4% during the 2nd quarter. Calamos Wealth Management LLC now owns 63,428 shares of the financial services provider’s stock worth $3,485,000 after acquiring an additional 3,796 shares during the last quarter. 76.24% of the stock is owned by institutional investors.

In related news, insider Christopher G. Townsend sold 55,712 shares of the stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now owns 25,181 shares in the company, valued at $1,367,076.49. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Christopher G. Townsend sold 82,731 shares of the stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the transaction, the insider now owns 49,660 shares in the company, valued at approximately $2,711,436. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

Several analysts have weighed in on MET shares. Goldman Sachs Group started coverage on shares of Metlife in a research note on Wednesday, October 18th. They issued a “conviction-buy” rating and a $61.00 price target for the company. ValuEngine downgraded shares of Metlife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 9th. Zacks Investment Research raised shares of Metlife from a “strong sell” rating to a “hold” rating in a research note on Monday, October 9th. Royal Bank of Canada reissued an “outperform” rating and issued a $60.00 price target (up from $56.00) on shares of Metlife in a research note on Friday, November 3rd. Finally, TheStreet raised shares of Metlife from a “c+” rating to a “b” rating in a research note on Wednesday, October 4th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $57.90.

Metlife Inc (NYSE:MET) opened at $53.03 on Thursday. Metlife Inc has a 52-week low of $44.26 and a 52-week high of $55.91. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a market cap of $55,800.00, a PE ratio of 115.28, a P/E/G ratio of 1.20 and a beta of 1.49.

Metlife (NYSE:MET) last posted its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, topping the consensus estimate of $0.90 by $0.19. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The business had revenue of $16.10 billion for the quarter, compared to analyst estimates of $15.47 billion. During the same quarter in the previous year, the firm posted $1.28 earnings per share. Metlife’s quarterly revenue was up 1.7% on a year-over-year basis. research analysts forecast that Metlife Inc will post 4.4 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Monday, February 5th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 annualized dividend and a dividend yield of 3.02%. Metlife’s dividend payout ratio is presently 347.83%.

WARNING: This piece of content was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://www.dailypolitical.com/2018/01/11/metlife-inc-met-shares-bought-by-windward-capital-management-co-ca.html.

About Metlife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.